Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as per
Molecular Weight:
419.38
Purity:
98%
Form:
White to off-white powder
CAS Number:
[1051375-16-6]
* VAT and and shipping costs not included. Errors and price changes excepted